Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial.

Cho SJ, Yook K, Kim B, Choi TK, Lee KS, Kim YW, Lee JE, Suh S, Yook KH, Lee SH.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):208-11. doi: 10.1016/j.pnpbp.2010.11.006. Epub 2010 Nov 21.

PMID:
21095214
2.

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.

Berk M, Gama CS, Sundram S, Hustig H, Koopowitz L, D'Souza R, Malloy H, Rowland C, Monkhouse A, Monkhouse A, Bole F, Sathiyamoorthy S, Piskulic D, Dodd S.

Hum Psychopharmacol. 2009 Apr;24(3):233-8. doi: 10.1002/hup.1017.

PMID:
19330802
3.

More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial.

Terevnikov V, Stenberg JH, Joffe M, Tiihonen J, Burkin M, Tchoukhine E, Joffe G.

Hum Psychopharmacol. 2010 Aug;25(6):431-8. doi: 10.1002/hup.1137.

PMID:
20737516
4.

The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial.

Abbasi SH, Behpournia H, Ghoreshi A, Salehi B, Raznahan M, Rezazadeh SA, Rezaei F, Akhondzadeh S.

Schizophr Res. 2010 Feb;116(2-3):101-6. doi: 10.1016/j.schres.2009.11.008. Epub 2009 Dec 2.

PMID:
19959338
5.

The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study.

Zoccali R, Muscatello MR, Cedro C, Neri P, La Torre D, Spina E, Di Rosa AE, Meduri M.

Int Clin Psychopharmacol. 2004 Mar;19(2):71-6.

PMID:
15076014
6.

A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.

Akdede BB, Anil Yağcioğlu AE, Alptekin K, Turgut TI, Tümüklü M, Yazici MK, Jayathilake K, Tunca Z, Göğüş A, Meltzer HY.

J Clin Psychiatry. 2006 Dec;67(12):1912-9.

PMID:
17194269
8.

Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.

Delle Chiaie R, Salviati M, Fiorentini S, Biondi M.

Exp Clin Psychopharmacol. 2007 Dec;15(6):563-8. doi: 10.1037/1064-1297.15.6.563.

PMID:
18179309
9.

More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia.

Stenberg JH, Terevnikov V, Joffe M, Tiihonen J, Tchoukhine E, Burkin M, Joffe G.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1080-6. doi: 10.1016/j.pnpbp.2011.03.004. Epub 2011 Mar 21.

PMID:
21402120
10.

Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.

Zhong KX, Sweitzer DE, Hamer RM, Lieberman JA.

J Clin Psychiatry. 2006 Jul;67(7):1093-103.

PMID:
16889453
11.

A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.

Anil Yağcioğlu AE, Kivircik Akdede BB, Turgut TI, Tümüklü M, Yazici MK, Alptekin K, Ertuğrul A, Jayathilake K, Göğüş A, Tunca Z, Meltzer HY.

J Clin Psychiatry. 2005 Jan;66(1):63-72.

PMID:
15669890
12.

Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.

Rossi A, Mancini F, Stratta P, Mattei P, Gismondi R, Pozzi F, Casacchia M.

Acta Psychiatr Scand. 1997 Jan;95(1):40-3.

PMID:
9051159
13.

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S.

Hum Psychopharmacol. 2008 Mar;23(2):79-86.

PMID:
17972359
14.

Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1879-83. doi: 10.1016/j.pnpbp.2008.08.020. Epub 2008 Sep 4.

PMID:
18801405
15.

Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.

Loonen AJ, Doorschot CH, Oostelbos MC, Sitsen JM.

Eur Neuropsychopharmacol. 1999 Dec;10(1):51-7.

PMID:
10647097
16.
17.

A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.

Salimi S, Fotouhi A, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Mohammadi MR, Noorbala AA, Ahmadi-Abhari SA, Hajiazim M, Abbasi SH, Akhondzadeh S.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):726-32. Epub 2007 Nov 23.

PMID:
18096287
18.

A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.

Akhondzadeh S, Gerami M, Noroozian M, Karamghadiri N, Ghoreishi A, Abbasi SH, Rezazadeh SA.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1810-5. doi: 10.1016/j.pnpbp.2008.08.001. Epub 2008 Aug 7.

PMID:
18727948
19.

Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.

Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A.

Biol Psychiatry. 2006 Jun 1;59(11):1071-7. Epub 2006 Feb 21.

PMID:
16497273
20.

Supplemental Content

Support Center